Chemotherapy in hormone refractory prostate cancer: where do we stand?

Eur Urol. 2004 Dec;46(6):709-11. doi: 10.1016/j.eururo.2004.08.023.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Humans
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Treatment Failure

Substances

  • Antineoplastic Agents, Hormonal